SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-127257
Filing Date
2023-04-28
Accepted
2023-04-28 16:39:13
Documents
24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d358125ddef14a.htm   iXBRL DEF 14A 892027
6 GRAPHIC g358125g00g08.jpg GRAPHIC 99841
7 GRAPHIC g358125g00m77.jpg GRAPHIC 281151
8 GRAPHIC g358125g00m78.jpg GRAPHIC 207801
9 GRAPHIC g358125g11a01.jpg GRAPHIC 106504
10 GRAPHIC g358125g11a02.jpg GRAPHIC 78660
11 GRAPHIC g358125g11a03.jpg GRAPHIC 94651
12 GRAPHIC g358125g33z01.jpg GRAPHIC 138311
13 GRAPHIC g358125g40b71.jpg GRAPHIC 6303
14 GRAPHIC g358125g57t15.jpg GRAPHIC 27674
15 GRAPHIC g358125g88b19.jpg GRAPHIC 10691
  Complete submission text file 0001193125-23-127257.txt   4252269

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA itci-20221231.xsd EX-101.SCH 5191
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20221231_def.xml EX-101.DEF 4984
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20221231_lab.xml EX-101.LAB 7261
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20221231_pre.xml EX-101.PRE 4351
18 EXTRACTED XBRL INSTANCE DOCUMENT d358125ddef14a_htm.xml XML 185427
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36274 | Film No.: 23867315
SIC: 2834 Pharmaceutical Preparations